Article Versions Notes

Kao H-W, Kuo M-C, Huang Y-J, Chang H, Hu S-F, Huang C-F, Hung Y-S, Lin T-L, Ou C-W, Lien M-Y, et al. Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for IDH1/2 Mutation in Adult AML. Cancers. 2022; 14(24):6205. https://doi.org/10.3390/cancers14246205

Kao, Hsiao-Wen, Ming-Chung Kuo, Ying-Jung Huang, Hung Chang, Shu-Fen Hu, Chein-Fuang Huang, Yu-Shin Hung, Tung-Liang Lin, Che-Wei Ou, Ming-Yu Lien, and et al. 2022. "Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for IDH1/2 Mutation in Adult AML" Cancers 14, no. 24: 6205. https://doi.org/10.3390/cancers14246205

Kao, H.-W., Kuo, M.-C., Huang, Y.-J., Chang, H., Hu, S.-F., Huang, C.-F., Hung, Y.-S., Lin, T.-L., Ou, C.-W., Lien, M.-Y., Wu, J.-H., Chen, C.-C., & Shih, L.-Y. (2022). Measurable Residual Disease Monitoring by Locked Nucleic Acid Quantitative Real-Time PCR Assay for IDH1/2 Mutation in Adult AML. Cancers, 14(24), 6205. https://doi.org/10.3390/cancers14246205